ConductScience.org, home

Paper16137751

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J and 11 others. Gynecol Oncol, 2006. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Papers, record 16137751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16137751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
PubMed
Journal
Gynecol Oncol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2007-11-14
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kotsopoulos JJoanne
2Lubinski JJan
3Neuhausen SLSusan L
4Lynch HTHenry T
5Rosen BBarry
6Ainsworth PPeter
7Moller PPal
8Ghadirian PParviz
9Isaacs CClaudine
10Karlan BBeth
11Sun PPing
12Narod SASteven A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CocarcinogenesisMajor topic
Estrogen Replacement TherapyMajor topic
Genes, BRCA1Major topic
Genes, BRCA2Major topic
Germ-Line MutationMajor topic
Ovarian NeoplasmsMajor topic
Aged
Aged, 80 and over
Case-Control Studies
Female
Genetic Predisposition to Disease
Humans
Middle Aged

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA74415NCI NIH HHSUnited StatesR01CA074415PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
40428282The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).Diagnostics (Basel)2025https://conductscience.org/library/papers/40428282PubMed
39259360The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer.J Cancer Res Clin Oncol2024https://conductscience.org/library/papers/39259360PubMed
39086900The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39086900PubMed
37674925Epidemiology and risk factors for ovarian cancer.Prz Menopauzalny2023https://conductscience.org/library/papers/37674925PubMed
36614207The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows.Int J Mol Sci2023https://conductscience.org/library/papers/36614207PubMed
33885953Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.J Cancer Res Clin Oncol2021https://conductscience.org/library/papers/33885953PubMed
31849838Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.Front Endocrinol (Lausanne)2019https://conductscience.org/library/papers/31849838PubMed
25838159Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.Fam Cancer2015https://conductscience.org/library/papers/25838159PubMed
24824314Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.J Natl Cancer Inst2014https://conductscience.org/library/papers/24824314PubMed
23362014Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California.Cancer2013https://conductscience.org/library/papers/23362014PubMed
18812548Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.J Natl Cancer Inst2008https://conductscience.org/library/papers/18812548PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16137751

GET https://conductscience.org/api/papers/v1/16137751/authors